Mangoceuticals Inc. (MGRX)
NASDAQ: MGRX
· Real-Time Price · USD
1.63
0.05 (3.16%)
At close: Aug 15, 2025, 3:59 PM
1.55
-4.62%
After-hours: Aug 15, 2025, 04:03 PM EDT
Mangoceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Net Income | -4.84M | -1.95M | -2M | -2.39M | -2.37M | -2.57M | -1.8M | -2.28M | -2.56M | -673.65K | -975.32K | -329.49K | -19.6K | -17.7K |
Depreciation & Amortization | 292.78K | 721.79K | 252.00 | 3.21K | 6.22K | 6.29K | 6.29K | 6.22K | 6.08K | 3.86K | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 1.05M | 50.98K | 108.76K | 50.98K | 37.97K | 429.08K | 66.84K | 64.27K | 64.27K | 64.27K | 169.82K | n/a | n/a | n/a |
Other Working Capital | n/a | -24.13K | -56.1K | 42.3K | 1.57K | 21.25K | -29.94K | -43.67K | -18.21K | 55.92K | -62.05K | n/a | n/a | n/a |
Other Non-Cash Items | 2.08M | -7.87K | 744.37K | 1.05M | 420.55K | 745.78K | 84.75K | 378.77K | 701.76K | -96.09K | 267.2K | 226.58K | 889.00 | 181.00 |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -386.88K | n/a | n/a | n/a | -3.86K | n/a | n/a | n/a | n/a |
Change in Working Capital | 144.52K | 54.13K | -19.98K | -289.57K | 915.8K | 76.03K | -69.17K | 55.74K | -21.09K | 55.92K | -62.05K | 25K | n/a | n/a |
Operating Cash Flow | -2.27M | -1.13M | -1.17M | -1.58M | -991.13K | -1.7M | -1.71M | -1.78M | -1.81M | -649.56K | -600.35K | -77.9K | -18.71K | -17.52K |
Capital Expenditures | n/a | n/a | 4.00 | -4 | n/a | 3.52K | n/a | n/a | -3.52K | -40.57K | -2.53K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 65K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | 65K | n/a | 3.52K | n/a | n/a | -3.52K | -40.57K | -2.53K | n/a | n/a | n/a |
Debt Repayment | n/a | -37.5K | n/a | 100K | 87.5K | n/a | n/a | -89.2K | n/a | n/a | -25K | 24.93K | 50K | 39.27K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.29M | n/a | n/a | 1.5M | n/a | n/a | n/a | n/a | -78.26K | 499.5K | -25K | n/a | n/a | n/a |
Financial Cash Flow | 2.29M | 1.12M | 750K | 1.99M | 267.5K | 1.2M | n/a | 935.3K | 4.92M | 499.5K | 1.48M | 24.93K | 50K | 40.07K |
Net Cash Flow | 17.84K | -15.26K | -414.67K | 474.94K | -723.7K | -497.74K | -1.71M | -843.72K | 3.11M | -190.63K | 872.62K | -52.97K | 31.29K | 22.55K |
Free Cash Flow | -2.27M | -1.13M | -1.17M | -1.58M | -991.13K | -1.69M | -1.71M | -1.78M | -1.81M | -690.13K | -602.88K | -77.9K | -18.71K | -17.52K |